Angio-Proteomie is actively engaged in developing research reagents for Life Science. Its products range from antibodies, recombinant proteins, human primary endothelial cells, recombinant adenovirues, and small interfering (si)RNAs.
Meanwhile, Angio-Proteomie, is at its early stage to develop therapeutic whole human antibody using human B cell hybridoma approach.